0001562180-22-000353.txt : 20220107 0001562180-22-000353.hdr.sgml : 20220107 20220107211728 ACCESSION NUMBER: 0001562180-22-000353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Engelhart James CENTRAL INDEX KEY: 0001704255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 22519448 MAIL ADDRESS: STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP STREET 2: 234 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-01-06 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001704255 Engelhart James C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false Strategic Advisor Common Shares 2022-01-06 4 M false 3750.00 0.00 A 15234.00 D Common Shares 2022-01-06 4 F false 1532.00 123.86 D 13702.00 D Common Shares 2022-01-07 4 M false 3250.00 0.00 A 16952.00 D Common Shares 2022-01-07 4 F false 1279.00 128.87 D 15673.00 D Restricted Share Unit Award 2022-01-06 4 M false 3750.00 0.00 D Common Shares 3750.00 7500.00 D Employee Stock Option (Right to Buy) 128.87 2022-01-07 4 A false 26000.00 0.00 A 2032-01-07 Common Shares 26000.00 26000.00 D Restricted Share Unit Award 2022-01-07 4 A false 13000.00 0.00 A Common Shares 13000.00 13000.00 D Restricted Share Unit Award 2022-01-07 4 M false 3250.00 0.00 D Common Shares 3250.00 9750.00 D This balance includes 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Each restricted share unit represents the contingent right to receive one common share of the Issuer. The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. Not applicable. The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date. The reporting person was granted 13,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. /s/ James Engelhart 2022-01-07